The weekly litigation news digest is live. Subscribe now

IP Verse

Salts And Crystalline Forms Of An Apoptosis-Inducing Agent - EP2643322

The patent EP2643322 was granted to Abbvie on Aug 30, 2017. The application was originally filed on Nov 21, 2011 under application number EP11791401A. The patent is currently recorded with a legal status of "Revoked".

EP2643322

ABBVIE
Application Number
EP11791401A
Filing Date
Nov 21, 2011
Status
Revoked
Sep 24, 2019
Publication Date
Aug 30, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMay 30, 2018HGF -

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2008182845
DESCRIPTIONUS2010305122
DESCRIPTIONWO2005024636
DESCRIPTIONWO2005049593
INTERNATIONAL-SEARCH-REPORTUS2010184750
INTERNATIONAL-SEARCH-REPORTUS2010305122
INTERNATIONAL-SEARCH-REPORTWO2010065824
INTERNATIONAL-SEARCH-REPORTWO2010138588
OPPOSITIONWO2010065824
OPPOSITIONWO2010138588

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents